Not logged in Share Save
Prognostic value of measurable residual disease (MRD) for venetoclax in combination with hypomethylating agents in patients diagnosed with acute myeloid leukemia: validation of the ELN-2021 MRD recommendations Jimenez-Vicente, Carlos; Cardus, Aina; Castano-Diez, Sandra; Ramil, Guillermo; Garcia-Avila, Sara; Gomez-Perez, Lucia; Esteban, Daniel; Arribas, Iago; Sturla, Antonella Lucia; Lopez-Guerra, Monica; Martinez-Roca, Alexandra; Cortes-Bullich, Albert; Perez-Valencia, Amanda Isabel; Zugasti, Ines; Monge, Ines; Carcelero, Esther; Vall-Llovera, Ferran; Vives, Susana; Sierra, Jorge; Nomdedeu, Josep; Onate, Guadalupe; Garrido, Ana; Pratcorona, Marta; Pomares, Helena; Arnan, Montserrat; Guijarro, Francesca; Diaz-Beya, Marina; Esteve, Jordi Share Save
Hypomethylating agents plus venetoclax for high-risk MDS and CMML as bridge therapy to transplant: a GESMD study Zugasti, Ines; Lopez-Guerra, Monica; Castano-Diez, Sandra; Esteban, Daniel; Avendano, Alejandro; Pomares, Helena; Perez, Ana; Garcia-Avila, Sara; Conejo, Irene Padilla; de la Fuente Montes, Cristina; Martinez-Roca, Alexandra; Merchan, Beatriz; Jimenez-Vicente, Carlos; Guijarro, Francesca; Alamo, Jose Ramon; Cortes-Bullich, Albert; Torrecillas, Victor; Mont, Lucia; Carcelero, Esther; Riu, Gisela; Zamora, Lurdes; Bargay, Joan; Triguero, Ana; Suarez-Lledo, Maria; Salas, Maria Queralt; Lopez-Cadenas, Felix; Ramos, Fernando; Xicoy, Blanca; Valcarcel, David; Arnan, Montserrat; Martinez, Carmen; Rovira, Montserrat; Fernandez-Aviles, Francesc; Diez-Campelo, Maria; Esteve, Jordi Share Save
Prognostic Value of the Measurable Residual Disease (MRD) in AML Treatment with Venetoclax in Combination with Hypomethylating Agents: Validation of the ELN 2021 MRD Recommendations Jimenez-Vicente, Carlos; Cardus, Aina; Lopez, Guillermo Ramil; Onate, Guadalupe; Arribas, Iago; Garcia-Avila, Sara; Gomez-Perez, Lucia; Esteban, Daniel; Sturla, Antonella; Guijarro, Francesca; Lopez-Guerra, Monica; Castano-Diez, Sandra; Martinez-Roca, Alexandra; Cortes-Bullich, Albert; Perez, Amanda Isabel; Zugasti, Ines; Monge-Escartin, Ines; Sierra, Jorge; Vives, Susana; Pomares, Helena; Arnan, Montserrat; Nomdedeu, Josep; Garrido, Ana; Pratcorona, Marta; Diaz-Beya, Marina; Esteve, Jordi Share Save
Genomic Instability in Early-Onset Myelodysplastic Syndrome Patients Harboring Rare Germline Variants in NHEJ DNA Repair Genes Gabarros-Subira, Maria; Miguez, Carlos Perez; Jauregui, Sandra Novoa; Diaz-Arias, Jose Angel; Chen, Tzu Hua; Torres-Esquius, Sara; Sama-Barroso, Araceli; Pomares, Helena; Ezponda, Teresa; Arnan, Montserrat; Diez-Campelo, Maria; Crucitti, Davide; Pierola, Ana Alfonso; Del Rey, Monica; Palomo, Laura; Bosch, Francesc; Ferreiras, David Valcarcel; Montoro, Julia; Orgueira, Adrian Mosquera; Jerez, Andres Share Save
Comparative Analysis of NGS and Digital PCR for Measurable Residual Disease Monitoring in Intensively Treated Acute Myeloid Leukemia Patients Lopez, Guillermo Ramil; Baleri, Alicia Artigas; Vilalta, Anna Gine; Onate, Guadalupe; Castellet, Helena; Diaz-Beya, Marina; Tormo, Mar; Cervera, Marta; Coll, Rosa; Serra, Jorge Jose Martinez; Vives, Susana; Garcia, Antonio; Riera, Martin Mascaro; Garcia, Sara; Calmet, Ferran Vall-Llovera; Arnan, Montserrat; Salamero, Olga; Diaz, Ana Garrido; Reyner, Jordi Esteve; Guinot, Josep F. Nomdedeu; Sierra, Jorge; Pratcorona, Marta Share Save
A phase 2, multicenter, clinical trial of CPX-351 in older patients with secondary or high-risk acute myeloid leukemia: PETHEMA-LAMVYX Rodriguez-Arboli, Eduardo; Rodriguez-Veiga, Rebeca; Soria-Saldise, Elena; Bergua, Juan M.; Caballero-Velazquez, Teresa; Arnan, Montserrat; Vives, Susana; Serrano, Josefina; Bernal, Teresa; Martinez-Sanchez, Pilar; Tormo, Mar; Rodriguez-Medina, Carlos; Herrera-Puente, Pilar; Lavilla-Rubira, Esperanza; Boluda, Blanca; Acuna-Cruz, Evelyn; Cano, Isabel; Caceres, Sara; Ballesteros, Juan; Falantes, Jose; Martinez-Cuadron, David; Perez-Simon, Jose A.; Montesinos, Pau Share Save
Iadademstat in combination with azacitidine in patients with newly diagnosed acute myeloid leukaemia (ALICE) :an open-label, phase 2a dose-finding study Salamero, Olga; Molero, Antonieta; Perez-Simon, Jose Antonio; Arnan, Montserrat; Coll, Rosa; Garcia-Avila, Sara; Acuna-Cruz, Evelyn; Cano, Isabel; Somervaille, Tim C. P.; Gutierrez, Sonia; Arevalo, Maria Isabel; Xaus, Jordi; Buesa, Carlos; Limon, Ana; Faller, Douglas, V; Bosch, Francesc; Montesinos, Pau Share Save
Chronic myelomonocytic leukemia with ring sideroblasts/SF3B1 mutation presents with low monocyte count and resembles myelodysplastic syndromes with-RS/SF3B1 mutation in terms of phenotype and prognosis Xicoy, Blanca; Pomares, Helena; Morgades, Mireia; Germing, Ulrich; Arnan, Montserrat; Tormo, Mar; Palomo, Laura; Orna, Elisa; Della Porta, Matteo; Schulz, Felicitas; Diaz-Beya, Marina; Esteban, Ada; Molero, Antonieta; Lanino, Luca; Avendano, Alejandro; Hernandez, Francisca; Roldan, Veronica; Ubezio, Marta; Pineda, Alberto; Diez-Campelo, Maria; Zamora, Lurdes Share Save
Biological basis of extensive pleiotropy between blood traits and cancer risk Pardo-Cea, Miguel Angel; Farre, Xavier; Esteve, Anna; Palade, Joanna; Espin, Roderic; Mateo, Francesca; Alsop, Eric; Alorda, Marc; Blay, Natalia; Baiges, Alexandra; Shabbir, Arzoo; Comellas, Francesc; Gomez, Antonio; Arnan, Montserrat; Teule, Alex; Salinas, Monica; Berrocal, Laura; Brunet, Joan; Rofes, Paula; Lazaro, Conxi; Conesa, Miquel; Rojas, Juan Jose; Velten, Lars; Fendler, Wojciech; Smyczynska, Urszula; Chowdhury, Dipanjan; Zeng, Yong; He, Housheng Hansen; Li, Rong; Van Keuren-Jensen, Kendall; de Cid, Rafael; Pujana, Miquel Angel Share Save
Sabatolimab plus hypomethylating agents in previously untreated patients with higher-risk myelodysplastic syndromes (STIMULUS-MDS1): a randomised, double-blind, placebo-controlled, phase 2 trial Zeidan, Amer M.; Ando, Kiyoshi; Rauzy, Odile; Turgut, Mehmet; Wang, Ming -Chung; Cairoli, Roberto; Hou, Hsin-An; Kwong, Yok-Lam; Arnan, Montserrat; Meers, Stef; Pullarkat, Vinod; Santini, Valeria; Malek, Kamel; Kiertsman, Flavia; Niolat, Julie; Ramos, Pedro Marques; Menssen, Hans D.; Fenaux, Pierre; Miyazaki, Yasushi; Platzbecker, Uwe Share Save
NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapy Hurtado-Navarro, Laura; Cuenca-Zamora, Ernesto Jose; Zamora, Lurdes; Bellosillo, Beatriz; Such, Esperanza; Soler-Espejo, Eva; Martinez-Banaclocha, Helios; Hernandez-Rivas, Jesus M.; Marco-Ayala, Javier; Martinez-Alarcon, Laura; Linares-Latorre, Lola; Garcia-Avila, Sara; Amat-Martinez, Paula; Gonzalez, Teresa; Arnan, Montserrat; Pomares-Marin, Helena; Carreno-Tarragona, Gonzalo; Chen-Liang, Tzu Hua; Herranz, Maria T.; Garcia-Palenciano, Carlos; Luz Morales, Maria; Jerez, Andres; Lozano, Maria L.; Teruel-Montoya, Raul; Pelegrin, Pablo; Ferrer-Marin, Francisca Share Save
Cusatuzumab plus azacitidine in newly diagnosed acute myeloid leukaemia ineligible for intensive chemotherapy (CULMINATE): part one of a randomised, phase 2, dose optimisation study Pabst, Thomas; Papayannidis, Cristina; Demirkan, Fatih; Doronin, Vadim; Fogliatto, Laura M.; Guttke, Christina; Gyan, Emmanuel; Hamad, Nada; Herrera, Pilar; Hultberg, Anna; Jacobs, Julie; Johnson, Amy J.; Langlois, Angelique; Ma, Xuewen; Martinelli, Giovanni; Arnan, Montserrat; Mueller, Rouven; Nottage, Kerri; Ofran, Yishai; Ozcan, Muhit; Samoilova, Olga; Tolbert, Jaszianne A.; Trudel, Geralyn C.; Xiu, Liang; Vey, Norbert; Wei, Andrew Share Save
Olutasidenib (FT-2102) induces durable complete remissions in patients with relapsed or refractory IDH1-mutated AML de Botton, Stephane; Fenaux, Pierre; Yee, Karen; Recher, Christian; Wei, Andrew H.; Montesinos, Pau; Taussig, David C.; Pigneux, Arnaud; Braun, Thorsten; Curti, Antonio; Grove, Carolyn; Jonas, Brian A.; Khwaja, Asim; Legrand, Ollivier; Peterlin, Pierre; Arnan, Montserrat; Blum, William; Cilloni, Daniela; Hiwase, Devendra K.; Jurcic, Joseph G.; Krauter, Juergen; Thomas, Xavier; Watts, Justin M.; Yang, Jay; Polyanskaya, Olga; Brevard, Julie; Sweeney, Jennifer; Barrett, Emma; Cortes, Jorge Share Save
Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort Onate, Guadalupe; Pratcorona, Marta; Garrido, Ana; Artigas-Baleri, Alicia; Bataller, Alex; Tormo, Mar; Arnan, Montserrat; Vives, Susana; Coll, Rosa; Salamero, Olga; Vall-Llovera, Ferran; Sampol, Antonia; Garcia, Antoni; Cervera, Marta; Avila, Sara Garcia; Bargay, Joan; Ortin, Xavier F.; Nomdedeu, Josep; Esteve, Jordi; Sierra, Jorge Share Save
Geriatric assessment in hematology scale predicts treatment tolerability in older patients diagnosed with hematological malignancies: The RETROGAH study Rubia, Javier de la; Gonzalez, Bernardo; Cruz-Jentoft, Alfonso J.; Iglesias, Lorena; Jarque, Isidro; Persona, Ernesto Perez; Lluch, Rafael; Marrero, Carmen; Zudaire, Maite; Gironella, Mercedes; Hernandez-Rivas, Jose Angel; Arnan, Montserrat; Olivier, Carmen; Encinas, Cristina; Soler, Juan Alfonso; Payer, Angel Ramirez; Casado, Alfonso; Fernandez, Patricia; Vilanova, David; Bonanad, Santiago Share Save
Olutasidenib alone or with azacitidine in IDH1-mutated acute myeloid leukaemia and myelodysplastic syndrome: phase 1 results of a phase 1/2 trial Watts, Justin M.; Baer, Maria R.; Yang, Jay; Prebet, Thomas; Lee, Sangmin; Schiller, Gary J.; Dinner, Shira N.; Pigneux, Arnaud; Montesinos, Pau; Wang, Eunice S.; Seiter, Karen P.; Wei, Andrew H.; De Botton, Stephane; Arnan, Montserrat; Donnellan, Will; Schwarer, Anthony P.; Recher, Christian; Jonas, Brian A.; Ferrell Jr, P. Brent; Marzac, Christophe; Kelly, Patrick; Sweeney, Jennifer; Forsyth, Sanjeev; Guichard, Sylvie M.; Brevard, Julie; Henrick, Patrick; Mohamed, Hesham; Cortes, Jorge E. Share Save
European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol Bataller, Alex; Garrido, Ana; Guijarro, Francesca; Onate, Guadalupe; Diaz-Beya, Marina; Arnan, Montserrat; Tormo, Mar; Vives, Susana; de Llano, Maria Paz Queipo; Coll, Rosa; Gallardo, David; Vall-Llovera, Ferran; Escoda, Lourdes; Garcia-Guinon, Antonio; Salamero, Olga; Sampol, Antonia; Merchan, Brayan M.; Bargay, Joan; Castano-Diez, Sandra; Esteban, Daniel; Oliver-Caldes, Aina; Rivero, Andrea; Mozas, Pablo; Lopez-Guerra, Monica; Pratcorona, Marta; Zamora, Lurdes; Costa, Dolors; Rozman, Maria; Nomdedeu, Josep F.; Colomer, Dolors; Brunet, Salut; Sierra, Jorge; Esteve, Jordi Share Save
Prognostic impact of DNMT3A mutation in acute myeloid leukemia with mutated NPM1 Onate, Guadalupe; Bataller, Alex; Garrido, Ana; Hoyos, Montserrat; Arnan, Montserrat; Vives, Susana; Coll, Rosa; Tormo, Mar; Sampol, Antonia; Escoda, Lourdes; Salamero, Olga; Garcia, Antoni; Bargay, Joan; Aljarilla, Alba; Nomdedeu, Josep F.; Esteve, Jordi; Sierra, Jorge; Pratcorona, Marta Share Save
Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study Pleyer, Lisa; Leisch, Michael; Kourakli, Alexandra; Padron, Eric; Maciejewski, Jaroslaw Pawel; Cirici, Blanca Xicoy; Kaivers, Jennifer; Ungerstedt, Johanna; Heibl, Sonja; Patiou, Peristera; Hunter, Anthony Michael; Mora, Elvira; Geissler, Klaus; Dimou, Maria; Lorenzo, Maria-Jose Jimenez; Melchardt, Thomas; Egle, Alexander; Viniou, Athina-Nora; Patel, Bhumika Jayantibhai; Arnan, Montserrat; Valent, Peter; Roubakis, Christoforos; Castillo, Teresa Bernal del; Galanopoulos, Athanasios; Munoz, Marisa Calabuig; Bonadies, Nicolas; de Almeida, Antonio Medina; Cermak, Jaroslav; Jerez, Andres; Montoro, Maria Julia; Cortes, Albert; Pita, Alejandro Avendano; Andrade, Bernardo Lopez; Hellstroem-Lindberg, Eva; Germing, Ulrich; Sekeres, Mikkael Aaron; List, Alan Francis; Symeonidis, Argiris; Sanz, Guillermo Francisco; Larcher-Senn, Julian; Greil, Richard Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
